Sarah B. Noonberg, Chief Medical Officer of Metagenomi, Inc. ($MGX), made one open market sale of common shares in the last year, totaling $9,168. Her most recent sale occurred on June 6, 2025. This ranks her 11,289th out of 11,678 individual insiders by sale value, well below the average of $8.6 million across 6.4 transactions. She reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 20, 2026 | Neurogene Inc. | $NGNE | Noonberg Sarah B. | Director | A | Non-Qualified Stock Option (right to buy) | 12050 | $0.00 | 12,050.0000 | 21,168,431 | 9999.99% | 0.06% |
| June 12, 2025 | Neurogene Inc. | $NGNE | Noonberg Sarah B. | Director | A | Non-Qualified Stock Option (right to buy) | 12050 | $0.00 | 12,050.0000 | 17,567,082 | 9999.99% | 0.07% |
| June 6, 2025 | Metagenomi Therapeutics, Inc. | $MGX | Noonberg Sarah B. | Chief Medical Officer | S | Common Stock | 5239 | $1.75 | 109,135.0000 | 1,870,923 | 4.58% | 0.28% |
| April 1, 2025 | Metagenomi Therapeutics, Inc. | $MGX | Noonberg Sarah B. | Chief Medical Officer | A | Common Stock | 14000 | $0.00 | 114,374.0000 | 1,870,923 | 13.95% | 0.75% |
| April 1, 2025 | Metagenomi Therapeutics, Inc. | $MGX | Noonberg Sarah B. | Chief Medical Officer | A | Stock Option (Right to Buy) | 84000 | $0.00 | 84,000.0000 | 1,870,923 | 9999.99% | 4.49% |
| June 14, 2024 | Neurogene Inc. | $NGNE | Noonberg Sarah B. | Director | A | Stock Option (Right to Buy) | 7700 | $0.00 | 7,700.0000 | 4,656,947 | 9999.99% | 0.17% |
| April 1, 2024 | Metagenomi Therapeutics, Inc. | $MGX | Noonberg Sarah B. | Chief Medical Officer | A | Common Stock | 57763 | $0.00 | 100,374.0000 | 3,884,740 | 135.56% | 1.49% |
| April 1, 2024 | Metagenomi Therapeutics, Inc. | $MGX | Noonberg Sarah B. | Chief Medical Officer | A | Stock Option (Right to Buy) | 242875 | $0.00 | 242,875.0000 | 3,884,740 | 9999.99% | 6.25% |
| Jan. 16, 2024 | Neurogene Inc. | $NGNE | Noonberg Sarah B. | Not found | A | Stock Option (Right to Buy) | 15400 | $0.00 | 15,400.0000 | 4,656,947 | 9999.99% | 0.33% |